Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by JAKPUG4LIFEon Nov 02, 2021 6:50pm
44 Views
Post# 34079747

RE:RE:FSD Pharma

RE:RE:FSD Pharma A lot of skin my arsse........... "Durkacz has received an astounding sum of over C$28.7 million total current value in cash and warrants for being both a director and broker for FSD... First Republic Capital collected massive fees for raising money for FSD Pharma. Anthony Durkacz controls and is a shareholder for First Republic. The amount of payments and warrants his company has received have been egregious, in our opinion; and FSD Pharma has made Durkacz a very wealthy man before the company has accomplished anything or made any profits."(1)
Mil_Man54 wrote: There's no shorting happening here pumper......but I guess when you ignore the data it makes it easy to say anything you want....or more to the point....say anything AD wants you to say....

DavidRosenberg wrote: For those still holding I'm sorry that you guys lost a lot of money I also lost a lot of money

Ignore the shorts trying to play with your emotions 

AD has alot of skin in this and would equally want to see the company succeed.

so hopefully they can wisely advance lucid drugs in 2022 




<< Previous
Bullboard Posts
Next >>